For instance, Zhao et al. proposed that the gene AURKA could serve as a prognostic biomarker for NB [24], while Liu et al. suggested that EIF2S1, by regulating the expression of GPX4 and SLC7A11, may act as a potential therapeutic target for inducing ferroptosis in NB cells [25]. This evidence concerns the gene EIF2S1 and neuroblastoma.